{
  "meta": {
    "title": "Cancer_Genes",
    "url": "https://brainandscalpel.vercel.app/cancer-genes-4f2a60f3.html",
    "scrapedAt": "2025-11-29T18:32:22.469Z"
  },
  "questions": [
    {
      "id": 13635,
      "choices": [
        {
          "id": 54501,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">E6</span></span></span></span></p>"
        },
        {
          "id": 54502,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">E7</span></span></span></span></p>"
        },
        {
          "id": 54503,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LMP1</span></span></span></span></p>"
        },
        {
          "id": 54504,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tax</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 28-year-old female presents with persistent cervical dysplasia on Pap smear. Further investigation reveals infection with high-risk HPV. Molecular analysis indicates the presence of a viral protein that interferes with the tumor suppressor Rb gene, promoting cell cycle progression. Which of the following protein produced by HPV suppresses Rb gene?</span></span></p>",
      "unique_key": "Q6607128",
      "question_audio": null,
      "question_video": null,
      "map_id": 32305,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) E7</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> E7</strong> protein of<strong> HPV </strong>binds to and leads to the<strong> degradation of the Rb tumor suppressor protein</strong>, allowing for the <strong>progression </strong>of the <strong>cell cycle </strong>and potentially <strong>leading to carcinogenesis.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A.&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>E6 protein of HPV </strong>is involved in the degradation of the<strong> p53 tumor suppressor protein</strong>, <strong>not the Rb protein</strong>. <strong>p53 </strong>is another <strong>critical regulator of the cell cycle and apoptosis.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C.</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>&nbsp;LMP1 </strong>is an<strong> oncogenic protein </strong>associated with <strong>Epstein-Barr virus (EBV), not HPV. </strong>It is involved in the development of various<strong> lymphomas and nasopharyngeal carcinoma.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D.&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Tax </strong>is a protein associated with <strong>Human T-cell lymphotropic virus type 1 (HTLV-1), not HPV. </strong>It plays a role in the development of<strong> adult T-cell leukemia/lymphoma (ATLL).</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>E6 </strong>promotes the <strong>degradation of p53, and E7 inactivates the Rb protein</strong>, disrupting <strong>normal cell cycle control </strong>and contributing to the risk of<strong> cervical cancer development.</strong></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup>/324</span></span></strong></span></span></p>",
      "correct_choice_id": 54502,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "CriteriaBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13678,
      "choices": [
        {
          "id": 54673,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gene amplification</span></span></span></span></p>"
        },
        {
          "id": 54674,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chromosomal translocation</span></span></span></span></p>"
        },
        {
          "id": 54675,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Point mutation </span></span></span></span></p>"
        },
        {
          "id": 54676,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gene deletion</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient is diagnosed with a malignancy that is associated with an overexpression of the c-Myc gene. Which of the following is the most likely mechanism of this overexpression? </span></span></p>",
      "unique_key": "Q3401000",
      "question_audio": null,
      "question_video": null,
      "map_id": 32307,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Gene amplification</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Gene amplification </strong>results in<strong> multiple copies of a gene</strong>, leading to<strong> overexpression of the gene product</strong>. This mechanism is frequently responsible for the<strong> increased levels of the c-Myc protein</strong> in various cancers, as it increases the<strong> transcription of genes</strong> involved in<strong> cell growth and proliferation.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Chromosomal translocation:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While chromosomal translocations can result in <strong>c-Myc overexpression</strong>, such as the <strong>translocation seen in Burkitt lymphoma (t(8;14),</strong>&nbsp;it is less common than gene amplification for the <strong>overexpression of c-Myc </strong>in a broader range of malignancies.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Point mutation:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Point mutations can <strong>activate oncogenes </strong>or <strong>inactivate tumor suppressor genes, </strong>but they are not typically associated with the <strong>overexpression of c-Myc. Instead</strong>, they might alter the function of the resulting protein.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Gene deletion:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Gene deletion generally leads to a<strong> loss of gene function </strong>and is more commonly associated with <strong>tumor suppressor genes </strong>rather than<strong> proto-oncogenes like c-Myc. Deletion would not </strong>result in<strong> overexpression </strong>but rather in reduced expression or<strong> loss of function.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Gene amplification</strong> is a common mechanism for <strong>overexpression of the c-Myc gene </strong>in various malignancies, leading to <strong>increased cell</strong> <strong>growth and proliferation </strong>due to the <strong>extra copies of the gene </strong>being <strong>transcribed.</strong></span></span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>C-myc gene is a proto-oncogene</strong> that codes for a<strong> transcription factor </strong>involved in <strong>cell proliferation and differentiation</strong>. <strong>Overexpression of c-Myc </strong>is seen in many malignancies, and it is often due to <strong>gene amplification, </strong>which results in an<strong> increased number of copies of the gene</strong>. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Chromosomal translocations </strong>can also<strong> lead to c-Myc overexpression, </strong>but they are <strong>less common.</strong></span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 54673,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13639,
      "choices": [
        {
          "id": 54517,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cervical carcinoma</span></span></span></span></p>"
        },
        {
          "id": 54518,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oral carcinoma</span></span></span></span></p>"
        },
        {
          "id": 54519,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Laryngeal papillomatosis</span></span></span></span></p>"
        },
        {
          "id": 54520,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anorectal carcinoma</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient presents with a growth suspected to be related to a low risk HPV subtypes. &nbsp;Which of the following is most likely responsible with HPV strains 6 and 11?</span></span></p>",
      "unique_key": "Q5725248",
      "question_audio": null,
      "question_video": null,
      "map_id": 32306,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Laryngeal papillomatosis</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Laryngeal papillomatosis&nbsp;</strong>is caused by <strong>low-risk HPV strains</strong>, such as <strong>HPV-6 and HPV-11</strong>, which generally <strong>lead to benign </strong>conditions like <strong>warts and respiratory papillomatosis.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A.&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Cervical carcinoma&nbsp;</strong>is typically caused by<strong> high-risk HPV strains </strong>such as<strong> HPV-16 and HPV-18</strong>, <strong>not the low-risk strains </strong>that cause<strong> laryngeal papillomatosis</strong>.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B.&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Oral carcinoma&nbsp;</strong>can also be caused by<strong> high-risk HPV strains</strong>, particularly<strong> HPV-16</strong>, which is associated with <strong>oropharyngeal cancers</strong>.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D.&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Anorectal carcinoma&nbsp;</strong>is associated with<strong> high-risk HPV strains</strong>, similar to<strong> cervical and oral carcinomas</strong>.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Low-risk HPV strains</strong>, such as <strong>HPV-6 and HPV-11, </strong>are associated with<strong> benign conditions such as laryngeal papillomatosis, </strong>while <strong>high-risk HPV strains </strong>are associated with malignancies like <strong>cervical, oral, and anorectal carcinoma. </strong></span></span></span></span></p>",
      "correct_choice_id": 54519,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13629,
      "choices": [
        {
          "id": 54477,
          "text": "<p><span style=\"font-size:12.0pt;\">6</span></p>"
        },
        {
          "id": 54478,
          "text": "<p><span style=\"font-size:12.0pt;\">11</span></p>"
        },
        {
          "id": 54479,
          "text": "<p><span style=\"font-size:12.0pt;\">18</span></p>"
        },
        {
          "id": 54480,
          "text": "<p><span style=\"font-size:12.0pt;\">82</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A woman presents to the gynecology clinic with genital lesions, as shown in the image. Upon examination, these lesions tests positive for a high-risk HPV subtype. Which of the following HPV subtypes is most likely the causative agent of her condition?</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/02/untitled-550.jpg\" alt=\"\" width=\"300\" height=\"259\"></span></p>",
      "unique_key": "Q1855870",
      "question_audio": null,
      "question_video": null,
      "map_id": 32311,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) 18</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The question has an image showing <strong>multiple vagino cervical warts</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>HPV-18,&nbsp;</strong>along with<strong> HPV-16, are high-risk HPV subtypes </strong>that are strongly associated with <strong>cervical cancer and its precursor lesions</strong>. A patient with a <strong>high-risk HPV subtype and genital lesions </strong>may have a <strong>malignancy or a precursor to malignancy.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>HPV-6</strong> is associated with<strong> low-risk HPV infections, </strong>which typically cause<strong> genital warts</strong>, but are<strong> not highly associated with cervical cancer.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Similar to HPV-6</strong>,<strong> HPV-11 </strong>is also considered<strong> low-risk for cervical cancer </strong>and is more commonly associated with the development of<strong> genital warts</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>HPV 82</strong> is <strong>less commonly </strong>associated with<strong> cervical pathology </strong>and is<strong> not </strong>typically classified among the high-risk HPV subtypes responsible for <strong>cervical cancer</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>High-risk HPV subtypes</strong>, particularly <strong>HPV-16 and HPV-18</strong>, are most commonly associated with<strong> cervical cancer </strong>and<strong> its precursor lesions</strong>. While the scenario<strong> indicates a high-risk HPV subtype, </strong>the lesions depicted are characteristic of<strong> condylomata acuminata, </strong>typically caused by <strong>low-risk HPV subtypes.</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">HPV subtypes are broadly divided into:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">Low-risk (non-oncogenic): 6, 11, 42, 43, 44, etc.</span></li><li><span style=\"font-size:12.0pt;\">High-risk (oncogenic): 16, 18, 31, 33, 35, 45, 52, 58, etc.</span></li></ul></li><li><span style=\"font-size:12.0pt;\">HPV 6 &amp; 11:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">Commonly cause condyloma acuminata (genital warts)</span></li><li><span style=\"font-size:12.0pt;\">Benign, low malignant potential</span></li></ul></li><li><span style=\"font-size:12.0pt;\">HPV 18 (and also HPV 16):</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">High-risk, oncogenic subtypes</span></li><li><span style=\"font-size:12.0pt;\">Associated with cervical intraepithelial neoplasia, cervical carcinoma, and also high-grade vaginal/vulvar intraepithelial neoplasia</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Ref</u>: Robbins 10<sup>th</sup>/1001</strong></span></p>",
      "correct_choice_id": 54479,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13654,
      "choices": [
        {
          "id": 54577,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hodgkin&#39;s Lymphoma</span></span></span></span></p>"
        },
        {
          "id": 54578,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Burkitt&#39;s lymphoma</span></span></span></span></p>"
        },
        {
          "id": 54579,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nasopharyngeal Carcinoma</span></span></span></span></p>"
        },
        {
          "id": 54580,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Kaposi sarcoma</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old patient with a history of chronic immunosuppression presents with cutaneous lesions and EBV infection. EBV is involved in the pathogenesis of all except:</span></span></p>",
      "unique_key": "Q2163303",
      "question_audio": null,
      "question_video": null,
      "map_id": 32309,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Kaposi sarcoma</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Kaposi sarcoma </strong>is<strong> not </strong>associated with <strong>EBV </strong>but with<strong> Human herpesvirus 8 (HHV-8), </strong>also known as <strong>Kaposi sarcoma</strong>-<strong>associated herpesvirus (KSHV). </strong>This cancer commonly occurs in<strong> immunocompromised patients</strong>, such as those with <strong>HIV/AIDS</strong>.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Hodgkin&#39;s Lymphoma :&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>EBV </strong>is associated with a<strong> subset of Hodgkin&#39;s Lymphoma</strong>. In these cases, the <strong>virus </strong>is present in the <strong>malignant Reed-Sternberg cells </strong>and is thought to <strong>contribute to their formation</strong>.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Burkitt&#39;s lymphoma:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> &nbsp;EBV</strong> is closely associated with <strong>Burkitt&#39;s lymphoma, </strong>especially the<strong> endemic variant </strong>found in <strong>malaria-prone regions of Africa. </strong>The virus is believed to drive the<strong> proliferation of B cells </strong>which, through <strong>additional genetic mutations, </strong>can develop into this <strong>aggressive form of lymphoma.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Nasopharyngeal Carcinoma :&nbsp;</span></span></strong></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>EBV infection </strong>has been implicated in the<strong> development of nasopharyngeal carcinoma</strong>, particularly in populations where the<strong> cancer is endemic</strong>. The <strong>virus&#39;s DNA </strong>is often found in the<strong> malignant cells.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Kaposi sarcoma </strong>is<strong> not </strong>associated with <strong>EBV </strong>but is caused by<strong> HHV-8</strong>. While<strong> EBV is linked </strong>to various <strong>lymphomas and nasopharyngeal carcinoma</strong>, <strong>Kaposi sarcoma&#39;s pathogenesis involves a different herpesvirus.</strong></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins and Cotran pathologic basis of disease 10th edition page: 325-6</span></span></strong></span></span></p>",
      "correct_choice_id": 54580,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16878,
      "choices": [
        {
          "id": 67472,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chromosome 13</span></span></span></p>"
        },
        {
          "id": 67473,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chromosome 11 </span></span></span></p>"
        },
        {
          "id": 67474,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chromosome 17</span></span></span></p>"
        },
        {
          "id": 67475,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chromosome 22</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">BRCA 1 gene is located on: </span></span></p>",
      "unique_key": "Q1860501",
      "question_audio": null,
      "question_video": null,
      "map_id": 32308,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Chromosome 17 </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Tumor-suppressor gene</strong>, <strong>BRCA-1 </strong>(17q21) <strong>encodes </strong>a <strong>zinc finger protein</strong>, and the <strong>product </strong>therefore may function as a transcription factor. The gene appears to be<strong> involved in gene repair</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">BRCA-2</span></strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (13q12) is also <strong>associated with an increased incidence of breast cancer </strong>in <strong>men and women</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>BRCA 1 gene </strong>is located on <strong>Chromosome 17q </strong>and <strong>BRCA2 gene </strong>is located on <strong>chromosome 13q.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbin 10<sup>th</sup>/ 1045</span></strong></span></span></p>",
      "correct_choice_id": 67474,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "InstrumentsBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16855,
      "choices": [
        {
          "id": 67380,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">E6 </span></span></span></p>"
        },
        {
          "id": 67381,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">E7</span></span></span></p>"
        },
        {
          "id": 67382,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">LMP1 </span></span></span></p>"
        },
        {
          "id": 67383,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tax</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 28-year-old female presents with a history of persistent genital warts. Upon further investigation, it is found that the Human Papillomavirus (HPV) responsible for her condition produces a protein that interacts with the Retinoblastoma (Rb) tumor suppressor protein, leading to its degradation. Which of the following HPV proteins is involved in this process?</span></span></p>",
      "unique_key": "Q4607619",
      "question_audio": null,
      "question_video": null,
      "map_id": 32310,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) E7 </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>E7 protein </strong>produced by <strong>Human Papillomavirus </strong>(HPV) interacts with the <strong>Retinoblastoma </strong>(Rb) <strong>tumor suppressor protein</strong>, leading to its <strong>degradation or inactivation</strong>. This <strong>interaction </strong>disrupts the <strong>regulation of cell cycle progression </strong>and <strong>promotes cell proliferation</strong>, contributing to the oncogenic potential of HPV.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. E6&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>protein </strong>of <strong>HPV </strong>interacts with <strong>cellular proteins</strong>, including <strong>p53</strong>, leading to its <strong>degradation</strong>, which can disrupt cell cycle control and apoptosis regulation.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. LMP1:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Latent Membrane Protein 1 </strong>is a <strong>protein </strong>produced by the <strong>Epstein-Barr virus</strong>. It plays a role in oncogenesis by activating signaling pathways involved in cell proliferation and survival.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Tax&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is a <strong>protein </strong>produced by the <strong>Human T-cell Leukemia Virus type 1 </strong>(HTLV-1), not HPV. Tax protein is known to interact with various cellular proteins and pathways, promoting cell proliferation and inhibiting apoptosis.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>HPV E7 protein </strong>has a <strong>role in promoting cellular proliferation </strong>and <strong>potential oncogenesis </strong>through <strong>interaction </strong>with the <strong>retinoblastoma </strong>(Rb) <strong>tumor suppressor protein</strong>, leading to its <strong>degradation. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10th/e p324</span></strong></span></span></p>",
      "correct_choice_id": 67381,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}